🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether ranibizumab (Lucentis) wi...
Status
Completed
Location
California Retina Consultants
Start Date
2010-01
Trial ID
NCT01028248
Treatments Being Tested
Monthly, continuous anti-vegf therapy for patients presenting with active p...
Status
Unknown
Location
Retina Consultants of Hawaii, Inc
Start Date
2010-11
Trial ID
NCT01248117
Treatments Being Tested
Idiopathic Parafoveal Telangiectasia (IPT) \[also known as Idiopathic Perif...
Status
Completed
Location
Eye Center of Northern Colorado
Start Date
2010-10
Trial ID
NCT01205035
Treatments Being Tested
Anti-vascular endothelial growth factor therapy is the major intervention f...
Status
Unknown
Location
Wen-Bin Wei
Start Date
2022-01-01
Trial ID
NCT05222633
Treatments Being Tested
This study investigates the use of a high dose anti-VEGF agent for the trea...
Status
Completed
Location
The New York Eye Cancer Center
Start Date
2011-05
Trial ID
NCT01334879
Treatments Being Tested
This is a single-masked study to compare intravitreally administered 0.5 mg...
Status
Completed
Location
Vitreous Retina Macula Consultants of New York
Start Date
2010-05
Trial ID
NCT01115556
Treatments Being Tested
The purpose of this study is to compare the safety and effectiveness of thr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00557791
Treatments Being Tested
The purpose of this study is to determine whether 2.0mg Ranibizumab is effe...
Status
Terminated
Location
Greater Houston Retina Research
Start Date
2009-12
Trial ID
NCT01025232
Treatments Being Tested
This study is a phase 3, double-masked, randomized, study of the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00509795
Macular diseases often cases severe visual impairment. Recent clinical intr...
Status
Unknown
Location
Kagawa University Faculty of Medicine
Start Date
2014-12
Trial ID
NCT02321267
Treatments Being Tested